China Pharma Holdings, Inc. (CPHI)Healthcare | Drug Manufacturers - Specialty & Generic | Haikou, China | NYSE American
0.75 USD
-0.12
(-13.533%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 0.72 -0.03 (-0.033%) ⇩ (Oct. 13, 2026, 7:59 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 2:34 a.m. EDT
The immediate outlook remains deeply bearish due to a catastrophic multi-year price collapse and deteriorating fundamentals. The stock has suffered four consecutive years of negative annual returns, culminating in a nearly 98% loss over the last nine years, which serves as undeniable evidence of structural failure rather than a temporary dislocation. Underlying business quality is eroding, with revenue shrinking by 7.5% annually, operating margins plunging to -151%, and negative returns on both assets and equity. The balance sheet is fragile, carrying debt significantly higher than its book value and a current ratio of just 0.26, indicating severe liquidity stress. While recent news headlines suggest a massive 700% surge, this appears to be a speculative event driven by a capital raise rather than a reversal of the company's operational decay. With no dividend history to provide income and a statistical forecasting model offering virtually no confidence in future price movements, there is no safe entry point for investors. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.383776 |
| AutoARIMA | 0.451041 |
| AutoETS | 0.455801 |
| AutoTheta | 0.780844 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 24% |
| H-stat | 10.86 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.422 |
| Excess Kurtosis | -0.91 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 11.211 |
| Revenue per Share | 0.199 |
| Market Cap | 32,326,730 |
| Beta | 1.05 |
| Profit Margins | -114.33% |
| Website | https://www.chinapharmaholdings.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.5347594 |
| Address1 | No. 17, Jinpan Road |
| Address2 | Second Floor |
| All Time High | 20,495.76 |
| All Time Low | 0.38 |
| Ask | 0.7297 |
| Ask Size | 3,200 |
| Average Daily Volume10 Day | 9,154,300 |
| Average Daily Volume3 Month | 5,302,784 |
| Average Volume | 5,302,784 |
| Average Volume10Days | 9,154,300 |
| Beta | 1.047 |
| Bid | 0.701 |
| Bid Size | 400 |
| Book Value | 0.893 |
| City | Haikou |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | China |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.7514 |
| Current Ratio | 0.261 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 0.869 |
| Day Low | 0.693 |
| Debt To Equity | 11.211 |
| Display Name | China Pharma |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,620,995,400 |
| Earnings Timestamp Start | 1,620,995,400 |
| Ebitda | -1,440,699 |
| Ebitda Margins | -0.36808 |
| Enterprise To Ebitda | -25.042 |
| Enterprise To Revenue | 9.217 |
| Enterprise Value | 36,078,028 |
| Eps Trailing Twelve Months | -0.42 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fax | 86 89 8668 19024 |
| Fifty Day Average | 0.8832 |
| Fifty Day Average Change | -0.1318 |
| Fifty Day Average Change Percent | -0.14923006 |
| Fifty Two Week Change Percent | -53.47594 |
| Fifty Two Week High | 19.19 |
| Fifty Two Week High Change | -18.4386 |
| Fifty Two Week High Change Percent | -0.9608442 |
| Fifty Two Week Low | 0.38 |
| Fifty Two Week Low Change | 0.3714 |
| Fifty Two Week Low Change Percent | 0.9773684 |
| Fifty Two Week Range | 0.38 - 19.19 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,019,050,200,000 |
| Float Shares | 3,300,648 |
| Free Cashflow | 1,106,281 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 215 |
| Fullday Change | -0.15900004 |
| Fullday Change Percent | -18.296896 |
| Fullday Price | 0.7514 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.11757 |
| Gross Profits | 460,174 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.89632004 |
| Held Percent Institutions | 0.0047400002 |
| Implied Shares Outstanding | 43,022,002 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,744,675,200 |
| Last Split Factor | 1:10 |
| Long Business Summary | China Pharma Holdings, Inc. develops, manufactures, and markets pharmaceutical products for human use in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection for edema diseases, hypertension, acute renal failure, hyperkalemia, hypercalcemia, and acute drug poisoning; and Candesartan for hypertension. It offers Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and Pseudophedrine Hydrochlorida sustained release tablets, as well as Hepatocyte growth-promoting factors, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. In addition, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection for nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It supplies its products to hospitals and OTC pharmacies through provincial and municipal pharmaceutical logistics companies. The company is based in Haikou, the People's Republic of China. |
| Long Name | China Pharma Holdings, Inc. |
| Market | us_market |
| Market Cap | 32,326,730 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_24403297 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -4,474,888 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 30,975,411 |
| Open | 0.8409 |
| Operating Cashflow | -140,490 |
| Operating Margins | -1.5098399 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.16 |
| Phone | 86 89 8668 11730 |
| Post Market Change | -0.0334 |
| Post Market Change Percent | -4.445036 |
| Post Market Price | 0.718 |
| Post Market Time | 1,791,935,996 |
| Previous Close | 0.869 |
| Price Hint | 4 |
| Price To Book | 0.84143335 |
| Price To Sales Trailing12 Months | 8.259067 |
| Profit Margins | -1.14328 |
| Quick Ratio | 0.072 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.1176 |
| Regular Market Change Percent | -13.5328 |
| Regular Market Day High | 0.869 |
| Regular Market Day Low | 0.693 |
| Regular Market Day Range | 0.693 - 0.869 |
| Regular Market Open | 0.8409 |
| Regular Market Previous Close | 0.869 |
| Regular Market Price | 0.7514 |
| Regular Market Time | 1,791,921,600 |
| Regular Market Volume | 578,386 |
| Return On Assets | -0.09355 |
| Return On Equity | -0.20988001 |
| Revenue Growth | -0.075 |
| Revenue Per Share | 0.199 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 43,022,002 |
| Shares Percent Shares Out | 0.0014 |
| Shares Short | 61,859 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 195,771 |
| Short Name | China Pharma Holdings, Inc. |
| Short Percent Of Float | 0.002 |
| Short Ratio | 0.26 |
| Source Interval | 15 |
| Symbol | CPHI |
| Total Cash | 304,874 |
| Total Cash Per Share | 0.007 |
| Total Debt | 4,056,171 |
| Total Revenue | 3,914,090 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.42 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.8718 |
| Two Hundred Day Average Change | -0.12040001 |
| Two Hundred Day Average Change Percent | -0.13810508 |
| Type Disp | Equity |
| Volume | 578,386 |
| Website | https://www.chinapharmaholdings.com |
| Zip | 570,216 |